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Summary 
Deubiquitylating enzymes (DUBs) enhance the dynamics of the versatile 
ubiquitin (Ub) code by reversing and regulating cellular ubiquitylation processes 
at multiple levels. Here, we discovered that the uncharacterized human protein 
ZUFSP (Zinc finger with UFM1-specific peptidase domain protein), which has 
been annotated as a potentially inactive UFM1 protease, and its fission yeast 
homologue Mug105 define a previously unrecognized class of evolutionarily 
conserved cysteine protease DUBs. Human ZUFSP selectively interacts with and 
cleaves long K63-linked poly-Ub chains by means of tandem Ub-binding 
domains, while it displays poor activity towards mono- or di-Ub substrates. In 
cells, ZUFSP is recruited to and regulates K63-Ub conjugates at genotoxic stress 
sites, promoting chromosome stability upon replication stress in a manner 
dependent on its catalytic activity. Our findings establish ZUFSP (ZUP1) as a 
new type of linkage-selective cysteine peptidase DUB with a role in genome 
maintenance pathways. 
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Introduction 
Post-translational modifications of proteins by ubiquitin (Ub) play key regulatory 
roles in virtually all aspects of eukaryotic cell biology. Conjugation of Ub moieties to 
lysine residues in target proteins proceeds via a three-step cascade involving 
numerous E1, E2 and E3 enzymes, forming the basis of a complex Ub code that 
entails the modification of tens of thousands of individual sites distributed among a 
large number of substrates (Kim et al., 2011; Komander and Rape, 2012; Wagner et 
al., 2011). In addition to modifying other proteins, Ub can be conjugated to any of the 
seven internal lysine (K) residues or the N-terminal methionine within Ub itself, 
giving rise to eight distinct Ub chain linkages, all of which occur in cells and serve 
particular, albeit not in all cases well understood, functions (Elia et al., 2015; 
Komander and Rape, 2012; Kulathu and Komander, 2012). For instance, K11- and 
K48-linked Ub chains are major signals for proteasomal degradation, whereas K63-
linked ubiquitylation is a non-proteolytic modification with critical regulatory roles in 
a range of key cellular processes including the DNA damage response (DDR), innate 
immunity and membrane trafficking (Chen and Sun, 2009; Jackson and Durocher, 
2013; Komander and Rape, 2012; Wu and Karin, 2015). The functional outcome of 
individual Ub-dependent modifications is determined by a diverse range of cellular 
proteins harboring Ub-binding domains (UBDs), more than 20 types of which have 
been identified (Husnjak and Dikic, 2012). By recognizing particular Ub topologies 
via their UBDs, often in conjunction with direct interaction with the ubiquitylated 
ligand, these factors bind specific subsets of ubiquitylated proteins and link the 
modifications to appropriate effector pathways. 
 
In addition to its versatility, protein ubiquitylation is a highly dynamic and reversible 
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modification, due in large part to the existence of deubiquitylating enzymes (DUBs), 
around 100 of which are encoded by mammalian genomes (Mevissen and Komander, 
2017; Nijman et al., 2005). The majority of DUBs are cysteine proteases, comprising 
five distinct classes, while a small proportion belongs to the JAMM motif family of 
metalloproteases (Mevissen and Komander, 2017). Whereas many DUBs, including 
most members of the USP-type family, display little apparent selectivity for cleaving 
particular Ub chain topologies, a smaller subset including several JAMM and OTU 
family DUBs have a strong preference for hydrolysis of one or a few defined linkage 
types (Mevissen and Komander, 2017).   
 
Besides Ub, eukaryotic cells encode around a dozen small Ub-like modifier proteins 
(UBLs), many of which play well-defined and important cellular roles (Hochstrasser, 
2009; van der Veen and Ploegh, 2012). While the enzymatic cascades underlying 
attachment of most UBLs to target proteins are overall similar to the Ub conjugation 
machinery, they comprise far fewer enzymes and in most cases target a more narrow 
range of substrates. For instance, protein modification by UFM1, the cellular 
functions of which are not fully understood but include hematopoiesis and the 
endoplasmic reticulum stress response, appears to be catalyzed by single E1, E2 and 
E3 enzymes (Cai et al., 2015; Komatsu et al., 2004; Tatsumi et al., 2010; Tatsumi et 
al., 2011). Like DUBs, dedicated proteases for UFM1 and a number of other UBLs 
including SUMO, NEDD8 and ISG15 enable the reversibility of these modifications 
(Cope et al., 2002; Hickey et al., 2012; Kang et al., 2007; Malakhov et al., 2002).  
 
Here, we report the surprising discovery that human ZUFSP, an uncharacterized 
cysteine peptidase protein annotated as a potential, but most likely inactive UFM1-
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specific protease, is a DUB that selectively recognizes and cleaves long K63-linked 
poly-Ub chains to promote cellular responses to genotoxic stress. Our findings reveal 
the existence of a hitherto unrecognized type of evolutionarily conserved cysteine 
protease DUB that is distinct from the five known families of thiol DUBs, and whose 
catalytic activity has a role in maintaining chromosomal stability in human cells. 
 
 
Results  
ZUFSP is a cysteine protease DUB 
Several proteins with important roles in Ub-mediated responses to DNA damage, 
including the E3 ligases RNF168 and RNF169, interact with Ub at DNA damage sites 
via the Motif Interacting with Ubiquitin (MIU) (Doil et al., 2009; Lee et al., 2006; 
Panier et al., 2012; Penengo et al., 2006; Poulsen et al., 2012; Stewart et al., 2009). 
Through in silico searches for other potential MIU-containing DDR factors, we noted 
that the uncharacterized human protein ZUFSP (Zinc finger with UFM1-specific 
peptidase domain protein/C6orf113) contains a highly conserved MIU motif in its 
central portion (Fig. 1A; see also Fig. 2C). The modular domain organization of 
ZUFSP additionally includes four adjacent N-terminal Zinc finger motifs (ZnF) and a 
C-terminal peptidase domain with similarity to the UFM1-specific proteases UFSP1/2 
(Fig. 1A,B). Given that ZUFSP contains an MIU motif and co-purifies with RPA 
subunits (Tkac et al., 2016), we speculated that it might function in Ub-mediated 
genome maintenance pathways. Notably, while the ZUFSP peptidase domain shows 
similarity to established UFM1-specific proteases, it conspicuously lacks the catalytic 
histidine residue present in these proteins (Fig. 1B, red arrow) (Ha et al., 2011), and is 
therefore thought to be catalytically inactive. However, ZUFSP contains adjacent, 
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conserved His residues that could serve a catalytic function (Fig. 1B, green arrows), 
and given the presence of a potential MIU motif, we reasoned that ZUFSP might be a 
DUB. In support of this hypothesis, we found that human ZUFSP readily interacted 
with immobilized Ub (Fig. S1A). To begin to address whether ZUFSP has intrinsic 
DUB activity, we assayed for covalent trapping of ZUFSP by a vinyl sulfone (VS)-Ub 
probe, which irreversibly reacts with the active site cysteines present in most DUBs 
(Ovaa, 2007). Indeed, ectopically expressed ZUFSP reacted with Ub-VS but not 
SUMO1-VS in a manner dependent on the predicted catalytic cysteine residue, C360 
(Fig. 1C; Fig. S1B). Endogenous ZUFSP was also trapped by Ub-VS (Fig. 1D). 
Further supporting the notion that ZUFSP is a protease towards Ub but not UFM1, 
sequence alignment analysis revealed that the ZUFSP peptidase domain is more 
distantly related to the UFSP1/2 family than to the uncharacterized peptidase Mug105 
in S. pombe (Fig. 1E), which does not express UFM1 (Komatsu et al., 2004). While 
SpMug105 lacks the N-terminal domain harboring the ZnF and MIU motifs found in 
ZUFSP (Fig. 1A), we found that, like ZUFSP, it reacted with Ub-VS in a manner 
dependent on its putative active site cysteine (C42) that aligns with C360 in human 
ZUFSP (Fig. 1B,F). Importantly, in contrast to ZUFSP and Mug105, human UFSP2 
did not react with Ub-VS (Fig. S1C). Using purified recombinant ZUFSP, we 
detected clear protease activity of ZUFSP towards a minimal Ub-Rhodamine 
substrate that was fully abrogated by the C360A mutation (Fig. 1G). We conclude that 
ZUFSP has DUB activity by virtue of a C-terminal cysteine protease domain that is 
distinct from any known DUBs. 
 
ZUFSP selectively interacts with long K63-linked Ub chains via tandem UBDs 
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Having shown that ZUFSP is a DUB, we next interrogated its Ub-binding 
capabilities. Using N- and C-terminally truncated ZUFSP fragments immunopurified 
from cells, we found that the Ub-binding determinant(s) localized to the N-terminal 
portion (Fig. 2A,B). In addition to the MIU, we noted that the ZnF motif in immediate 
proximity to the MIU, but not ZnFs1-3, strongly resembles a UBZ3 domain, a type of 
Ub-binding C2H2 ZnF that also resides in, and crucially promotes the function of, the 
translesion DNA synthesis (TLS) polymerase Polη (Fig. 2A,C) (Bienko et al., 2005; 
Hofmann, 2009). We surmised that this configuration might impart preferential 
binding of ZUFSP to Ub chains, as has been reported for other tandem UBDs 
(Husnjak and Dikic, 2012; Sims and Cohen, 2009). Indeed, we found that ZUFSP was 
highly selective for interaction with poly-Ub chains and bound recombinant mono-, 
di- and tri-Ub inefficiently in vitro (Fig. 2D). Importantly, the Ub-binding ability of 
ZUFSP was diminished by specific point mutations within the MIU or UBZ domains 
and nearly abrogated by simultaneous mutation of both motifs (Fig. 2E), suggesting 
they cooperatively underlie high-affinity ZUFSP binding to poly-Ub chains. Tandem 
configurations of UBDs can confer linkage-specific binding to Ub chains (Husnjak 
and Dikic, 2012; Sims and Cohen, 2009). Interestingly, using purified tetra-Ub 
linkages, we noted that ZUFSP displays a remarkable preference for interaction with 
K63-linked chains (Fig. 2F), suggesting that it may be involved in regulation of K63 
ubiquitylation-mediated cellular processes. Varying the linker length between the 
UBZ and MIU motifs did not detectably affect the K63 chain-binding ability of 
ZUFSP (Fig. S1D), suggesting flexibility in the interdistance between these motifs.  
 
ZUFSP selectively deubiquitylates K63 poly-Ub chains 
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We next probed the ability of ZUFSP to cleave different Ub linkages. In line with its 
preference for binding long Ub chains, we found that all eight di-Ub linkages were 
poor substrates of recombinant wild-type (WT) ZUFSP in vitro (Fig. S1E). When 
presented with longer Ub chains, however, ZUFSP displayed potent and selective 
DUB activity towards K63-linked chains while hydrolyzing other poly-Ub chains 
inefficiently (Fig. 3A-D; Fig. S1F). Consistent with its lack of activity against Ub-
Rhodamine, the ZUFSP C360A mutant showed no detectable activity towards K63 
chains (Fig. 1D; Fig. 3D). As tetra-K27 Ub chains were not available to us, we cannot 
rule out that in addition to K63-linked chains ZUFSP may also be able to cleave this 
linkage type, although it showed little activity towards K27 di-Ub linkages (Fig. S1E). 
Because the tandem UBZ/MIU motifs in ZUFSP confer selectivity for binding to 
K63-linked poly-Ub chains, which are also the preferred substrate of ZUFSP, we next 
asked whether the Ub-binding N-terminus was needed for ZUFSP activity towards 
these chains. Kinetic analysis of ZUFSP activity against Ub-Rhodamine revealed a 2-
fold higher activity of full-length (FL) ZUFSP compared to the catalytic domain (CD) 
only (Fig. 3E). Detailed fitting of the data showed that the difference was in the KM 
(KM(FL)=4.9 μM; KM(CD)=10.5 μM), while the rates (kcat) were identical (kcat=0.084 
s-1) (Fig. S2A-C), predicting cleavage of maximally 9% bonds per min in the first 
turnover under the conditions of Fig. 3D (1 μM enzyme, ~3 μM octa-Ub chains (~21 
μM cleavable K63 linkages)), in good overall agreement with our findings. These 
kinetic constants also indicate that in comparison to a range of USP-type DUBs 
(Faesen et al., 2011), ZUFSP is a relatively slow enzyme towards minimal Ub 
substrates. Strikingly, when assayed for activity towards K63-linked poly-Ub chains, 
ZUFSP CD was virtually inactive, in contrast to ZUFSP FL (Fig. 3F). We conclude 
that ZUFSP selectively cleaves K63-linked poly-Ub chains in a manner that strictly 
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depends on its UBD-containing N-terminal portion, which may orient K63-linked 
chains for efficient hydrolysis by the peptidase domain.  
 
K63-Ub-dependent recruitment of ZUFSP to genotoxic stress sites 
As ZUFSP mainly localizes to the nucleus (Fig. 4A), contains MIU and UBZ domains 
and shows selectivity for binding to and processing K63-linked Ub chains, it shares 
several features with key DDR factors, and we therefore considered the possibility 
that ZUFSP functions in genome maintenance processes. Consistent with this idea, 
GFP-tagged ZUFSP was recruited to sites of localized DNA double-strand breaks 
(DSBs) induced by laser micro-irradiation or the FokI nuclease (Shanbhag and 
Greenberg, 2013) in a subset of cells (Fig. 4A,B; Fig. S3A). At the laser- and FokI-
induced DSB sites, ZUFSP preferentially co-localized with RPA, which demarcates 
single-stranded DNA (ssDNA) regions generated in proximity to the breaks (Fig. 
S3A,B). Analysis of ZUFSP mutants revealed that both the UBDs and the three N-
terminal ZnFs were required for ZUFSP accumulation at DNA damage sites (Fig. 2A; 
Fig. 4A,B). On the other hand, catalytically inactive ZUFSP formed foci in an 
increased proportion of cells, suggesting its potential trapping by one or more 
substrates at DNA damage sites (Fig. 4B). In line with the UBZ/MIU-mediated 
selective binding of ZUFSP to K63-linked Ub chains and the key role of this 
modification in promoting protein recruitment to DNA damage sites (Jackson and 
Durocher, 2013; Schwertman et al., 2016), knockdown of Ubc13, the major E2 Ub-
conjugating enzyme responsible for K63 chain formation (Hofmann and Pickart, 
1999) strongly impaired ZUFSP accumulation at DNA damage sites (Fig. 4C; Fig. 
S3C). Moreover, consistent with its enrichment at RPA-ssDNA regions at DSB sites, 
ZUFSP accumulation at FokI-induced DSBs was largely abrogated by knockdown of 
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CtIP, a critical mediator of DSB end-resection-generated ssDNA stretches (Fig. 4C; 
Fig. S3C) (Symington, 2014). However, despite ZUFSP associated with RPA in co-
immunoprecipitation experiments, this interaction did not depend on its UBDs and 
ZnF motifs, and ZUFSP recruitment to DSBs was unaffected by RPA depletion (Fig. 
4C; Fig. S3D), suggesting the involvement of additional factors and/or ssDNA 
binding per se. 
 
ZUFSP catalytic activity promotes responses to replication stress  
Extended ssDNA regions can form as a consequence of both DSB end-resection and 
replication stress (Symington, 2014; Zeman and Cimprich, 2014), raising the 
possibility that ZUFSP functions in these processes. While modulation of ZUFSP 
expression levels or functional status did not significantly impact end-resection, DSB 
repair efficiency and recruitment of key repair factors such as 53BP1 to DSB sites 
(Fig. S3E-H; data not shown), we uncovered a potential role for ZUFSP in promoting 
responses to replication stress. Specifically, loss of ZUFSP led to an elevated 
frequency of micronuclei in RPE-1 or U2OS cells subjected to replication stress 
induced by treatment with low doses of replication-perturbing agents including 
aphidicolin, hydroxyurea and camptothecin, indicative of an elevated level of 
chromosomal instability (Fig. 4D; Fig. S4A-D). Moreover, cells depleted of ZUFSP 
accrued more S phase-associated DNA damage and displayed an elevated proportion 
of DNA damage-containing (RPA foci-positive) micronuclei upon treatment with 
replication stress-inducing agents (Fig. 4E; Fig. S4E). This suggested that ZUFSP 
might facilitate DNA replication integrity during conditions of replication stress. In 
line with this, GFP-ZUFSP showed robust recruitment to a replication fork barrier 
induced by binding of LacR to an integrated LacO array at a single genomic locus 
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(Beuzer et al., 2014), with kinetics paralleling that of K63-Ub conjugates and PCNA 
(Fig. 4F; Fig. S4F). Knockdown of ZUFSP by independent siRNAs significantly 
increased K63-Ub levels at the LacR/LacO barrier (Fig. 4G), suggesting that ZUFSP 
regulates the K63 ubiquitylation status of one or more factors at replication stress 
sites. In addition, while loss of ZUFSP did not alter cell cycle distribution in 
unchallenged conditions, it markedly delayed cell cycle progression upon release 
from an HU-induced replication block, evidenced by a persistence of S phase cells at 
time points where the majority of control cells had completed DNA replication (Fig. 
4H; Fig. S4G). Expression of WT ZUFSP fully rescued this delay (Fig. 4H). Finally, 
the increased incidence of replication stress-induced micronuclei caused by ZUFSP 
loss could be restored by complementation with stably expressed WT ZUFSP, 
whereas catalytically inactive and Ub-binding deficient mutants failed to correct this 
defect (Fig. 4I; Fig. S4H). Together, these findings suggest that ZUFSP has a role in 
preserving chromosomal stability after perturbations to normal DNA replication that 
requires both its K63 ubiquitylation-directed DUB activity and ability to interact with 
genotoxic stress sites.  
 
 
Discussion 
The findings reported here demonstrate that despite having been considered a 
potentially inactive UFM1 peptidase, ZUFSP harbors potent, linkage-selective DUB 
activity, displaying a marked preference for interacting with and cleaving long K63 
poly-Ub chains. While the only other human protein that appears to contain a full 
ZUFSP-like peptidase domain is the UFM1-specific protease UFSP2, which we found 
has no detectable DUB activity, we note that this module is conserved through 
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eukaryotic evolution and that like human ZUFSP, the S. pombe orthologue Mug105 is 
also an active DUB. The ZUFSP/Mug105 family therefore appears to define a class of 
cysteine protease DUBs that is distinct from the five known thiol protease DUB 
families. Interestingly, ZUFSP has several features in common with MINDY-1, 
another recently identified human DUB whose biological function is unknown (Abdul 
Rehman et al., 2016). Accordingly, both of these factors show a clear preference for 
interacting with and cleaving long Ub chains and remarkable chain-trimming activity 
towards specific Ub linkages, mediated by tandem UBDs encompassing MIU motifs. 
However, in contrast to ZUFSP, MINDY-1 selectively recognizes and cleaves K48-
linked poly-Ub chains (Abdul Rehman et al., 2016). Structural analysis of full-length 
ZUFSP will be important to fully address the molecular basis of its selectivity for 
recognizing and hydrolyzing K63-linked poly-Ub chains. While we cannot formally 
rule out that ZUFSP may also possess catalytic activity towards UFM1, we currently 
have no in vitro or in vivo evidence supporting this possibility. Based on our 
collective findings, we suggest renaming ZUFSP as ZUP1 (Zinc finger containing 
Ubiquitin Peptidase 1). 
 
In line with the key role of K63-linked ubiquitylation in promoting the DDR (Jackson 
and Durocher, 2013; Schwertman et al., 2016), we uncovered an emerging function of 
ZUFSP DUB activity in maintaining chromosomal stability upon replication stress. 
Apart from the well-established role of K63-linked PCNA polyubiquitylation in 
promoting tolerance of DNA damage encountered during replication (Garcia-
Rodriguez et al., 2016), detailed mechanistic insights into how non-proteolytic K63 
ubiquitylation regulates responses to replication stress remain limited, and we have 
not obtained supportive evidence for a direct role of ZUFSP DUB activity in 
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reversing PCNA polyubiquitylation (data not shown). The selective activity of 
ZUFSP towards long K63-linked Ub chains suggests that it could function as a chain-
trimming enzyme working in conjunction with other Ub signaling factors to ensure 
the proper dynamics of K63 ubiquitylation-dependent modifications of one or more 
proteins residing in the context of RPA-ssDNA regions at genotoxic stress sites. The 
potential complexity of such Ub-mediated regulatory processes is underscored by the 
extensive range of DUBs that have been implicated in genotoxic stress responses, 
often playing partially redundant roles (Kee and Huang, 2015). Precisely how ZUFSP 
DUB activity promotes these and possibly other biological responses will therefore be 
important yet challenging subjects of future investigations. 
 
 
Acknowledgments 
We thank Roger Greenberg and Susan Janicki for providing reagents and Alexander 
Fish (NKI Protein Facility) for assistance with kinetic modeling. This work was 
supported by grants from Novo Nordisk Foundation (grants no. NNF14CC0001 and 
NNF15OC0016926), European Research Council (ERC, grant agreement no. 616236 
(DDRegulation)), Danish Council for Independent Research, The Lundbeck 
Foundation, Danish National Research Foundation (grant no. DNRF115), The Danish 
Cancer Society and The Dutch Cancer Society KWF (2015-8082). D.T. is a Marie 
Skłodowska-Curie Fellow (IF-Grant Number: 744866-ChroSoDSB). 
 
 
Author contributions 
 14 
Conceptualization, P.H. and N.M.; Methodology, P.H., N.B., X.G., D.T., D.A., S.H., 
R.S., T.S. and N.M. Investigation, P.H., N.B., X.G., D.T.; Writing – Original Draft, 
P.H. and N.M.; Writing – Review & Editing, P.H. and N.M.; Supervision, T.S. and 
N.M.; Project Administration, N.M.; Funding Acquisition, D.T., T.S. and N.M. 
 
 
Declaration of Interests 
The authors declare no competing interests. 
 
 
References 
Abdul Rehman, S.A., Kristariyanto, Y.A., Choi, S.Y., Nkosi, P.J., Weidlich, S., 
Labib, K., Hofmann, K., and Kulathu, Y. (2016). MINDY-1 Is a Member of an 
Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating 
Enzymes. Mol Cell 63, 146-155. 
Beuzer, P., Quivy, J.P., and Almouzni, G. (2014). Establishment of a replication fork 
barrier following induction of DNA binding in mammalian cells. Cell Cycle 13, 1607-
1616. 
Bienko, M., Green, C.M., Crosetto, N., Rudolf, F., Zapart, G., Coull, B., Kannouche, 
P., Wider, G., Peter, M., Lehmann, A.R., et al. (2005). Ubiquitin-binding domains in 
Y-family polymerases regulate translesion synthesis. Science 310, 1821-1824. 
Cai, Y., Pi, W., Sivaprakasam, S., Zhu, X., Zhang, M., Chen, J., Makala, L., Lu, C., 
Wu, J., Teng, Y., et al. (2015). UFBP1, a Key Component of the Ufm1 Conjugation 
System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development. 
PLoS Genet 11, e1005643. 
Chen, Z.J., and Sun, L.J. (2009). Nonproteolytic functions of ubiquitin in cell 
signaling. Mol Cell 33, 275-286. 
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., 
Jiang, W., Marraffini, L.A., et al. (2013). Multiplex genome engineering using 
CRISPR/Cas systems. Science 339, 819-823. 
Cope, G.A., Suh, G.S., Aravind, L., Schwarz, S.E., Zipursky, S.L., Koonin, E.V., and 
Deshaies, R.J. (2002). Role of predicted metalloprotease motif of Jab1/Csn5 in 
cleavage of Nedd8 from Cul1. Science 298, 608-611. 
Doil, C., Mailand, N., Bekker-Jensen, S., Menard, P., Larsen, D.H., Pepperkok, R., 
Ellenberg, J., Panier, S., Durocher, D., Bartek, J., et al. (2009). RNF168 binds and 
amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of 
repair proteins. Cell 136, 435-446. 
Elia, A.E., Boardman, A.P., Wang, D.C., Huttlin, E.L., Everley, R.A., Dephoure, N., 
Zhou, C., Koren, I., Gygi, S.P., and Elledge, S.J. (2015). Quantitative Proteomic Atlas 
 15 
of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell 59, 867-
881. 
Faesen, A.C., Luna-Vargas, M.P., Geurink, P.P., Clerici, M., Merkx, R., van Dijk, 
W.J., Hameed, D.S., El Oualid, F., Ovaa, H., and Sixma, T.K. (2011). The differential 
modulation of USP activity by internal regulatory domains, interactors and eight 
ubiquitin chain types. Chem Biol 18, 1550-1561. 
Garcia-Rodriguez, N., Wong, R.P., and Ulrich, H.D. (2016). Functions of Ubiquitin 
and SUMO in DNA Replication and Replication Stress. Front Genet 7, 87. 
Ha, B.H., Jeon, Y.J., Shin, S.C., Tatsumi, K., Komatsu, M., Tanaka, K., Watson, 
C.M., Wallis, G., Chung, C.H., and Kim, E.E. (2011). Structure of ubiquitin-fold 
modifier 1-specific protease UfSP2. J Biol Chem 286, 10248-10257. 
Hickey, C.M., Wilson, N.R., and Hochstrasser, M. (2012). Function and regulation of 
SUMO proteases. Nat Rev Mol Cell Biol 13, 755-766. 
Hochstrasser, M. (2009). Origin and function of ubiquitin-like proteins. Nature 458, 
422-429. 
Hofmann, K. (2009). Ubiquitin-binding domains and their role in the DNA damage 
response. DNA Repair (Amst) 8, 544-556. 
Hofmann, R.M., and Pickart, C.M. (1999). Noncanonical MMS2-encoded ubiquitin-
conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA 
repair. Cell 96, 645-653. 
Husnjak, K., and Dikic, I. (2012). Ubiquitin-binding proteins: decoders of ubiquitin-
mediated cellular functions. Annu Rev Biochem 81, 291-322. 
Jackson, S.P., and Durocher, D. (2013). Regulation of DNA damage responses by 
ubiquitin and SUMO. Mol Cell 49, 795-807. 
Janicki, S.M., Tsukamoto, T., Salghetti, S.E., Tansey, W.P., Sachidanandam, R., 
Prasanth, K.V., Ried, T., Shav-Tal, Y., Bertrand, E., Singer, R.H., et al. (2004). From 
silencing to gene expression: real-time analysis in single cells. Cell 116, 683-698. 
Johnson, K.A., Simpson, Z.B., and Blom, T. (2009a). FitSpace explorer: an algorithm 
to evaluate multidimensional parameter space in fitting kinetic data. Anal Biochem 
387, 30-41. 
Johnson, K.A., Simpson, Z.B., and Blom, T. (2009b). Global kinetic explorer: a new 
computer program for dynamic simulation and fitting of kinetic data. Anal Biochem 
387, 20-29. 
Kang, S.H., Kim, G.R., Seong, M., Baek, S.H., Seol, J.H., Bang, O.S., Ovaa, H., 
Tatsumi, K., Komatsu, M., Tanaka, K., et al. (2007). Two novel ubiquitin-fold 
modifier 1 (Ufm1)-specific proteases, UfSP1 and UfSP2. J Biol Chem 282, 5256-
5262. 
Kee, Y., and Huang, T.T. (2015). Role of Deubiquitinating Enzymes in DNA Repair. 
Mol Cell Biol 36, 524-544. 
Kim, W., Bennett, E.J., Huttlin, E.L., Guo, A., Li, J., Possemato, A., Sowa, M.E., 
Rad, R., Rush, J., Comb, M.J., et al. (2011). Systematic and quantitative assessment 
of the ubiquitin-modified proteome. Mol Cell 44, 325-340. 
Komander, D., and Rape, M. (2012). The ubiquitin code. Annu Rev Biochem 81, 203-
229. 
Komatsu, M., Chiba, T., Tatsumi, K., Iemura, S., Tanida, I., Okazaki, N., Ueno, T., 
Kominami, E., Natsume, T., and Tanaka, K. (2004). A novel protein-conjugating 
system for Ufm1, a ubiquitin-fold modifier. EMBO J 23, 1977-1986. 
Kulathu, Y., and Komander, D. (2012). Atypical ubiquitylation - the unexplored 
world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 13, 
508-523. 
 16 
Lee, S., Tsai, Y.C., Mattera, R., Smith, W.J., Kostelansky, M.S., Weissman, A.M., 
Bonifacino, J.S., and Hurley, J.H. (2006). Structural basis for ubiquitin recognition 
and autoubiquitination by Rabex-5. Nat Struct Mol Biol 13, 264-271. 
Luna-Vargas, M.P., Christodoulou, E., Alfieri, A., van Dijk, W.J., Stadnik, M., 
Hibbert, R.G., Sahtoe, D.D., Clerici, M., Marco, V.D., Littler, D., et al. (2011). 
Enabling high-throughput ligation-independent cloning and protein expression for the 
family of ubiquitin specific proteases. J Struct Biol 175, 113-119. 
Malakhov, M.P., Malakhova, O.A., Kim, K.I., Ritchie, K.J., and Zhang, D.E. (2002). 
UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 
277, 9976-9981. 
Mevissen, T.E.T., and Komander, D. (2017). Mechanisms of Deubiquitinase 
Specificity and Regulation. Annu Rev Biochem 86, 159-192. 
Mosbech, A., Gibbs-Seymour, I., Kagias, K., Thorslund, T., Beli, P., Povlsen, L., 
Nielsen, S.V., Smedegaard, S., Sedgwick, G., Lukas, C., et al. (2012). DVC1 
(C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-
dependent responses to replication blocks. Nat Struct Mol Biol 19, 1084-1092. 
Nijman, S.M., Luna-Vargas, M.P., Velds, A., Brummelkamp, T.R., Dirac, A.M., 
Sixma, T.K., and Bernards, R. (2005). A genomic and functional inventory of 
deubiquitinating enzymes. Cell 123, 773-786. 
Ovaa, H. (2007). Active-site directed probes to report enzymatic action in the 
ubiquitin proteasome system. Nat Rev Cancer 7, 613-620. 
Panier, S., Ichijima, Y., Fradet-Turcotte, A., Leung, C.C., Kaustov, L., Arrowsmith, 
C.H., and Durocher, D. (2012). Tandem protein interaction modules organize the 
ubiquitin-dependent response to DNA double-strand breaks. Mol Cell 47, 383-395. 
Penengo, L., Mapelli, M., Murachelli, A.G., Confalonieri, S., Magri, L., Musacchio, 
A., Di Fiore, P.P., Polo, S., and Schneider, T.R. (2006). Crystal structure of the 
ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin. 
Cell 124, 1183-1195. 
Poulsen, M., Lukas, C., Lukas, J., Bekker-Jensen, S., and Mailand, N. (2012). Human 
RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-
strand breaks. J Cell Biol 197, 189-199. 
Schwertman, P., Bekker-Jensen, S., and Mailand, N. (2016). Regulation of DNA 
double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat Rev Mol 
Cell Biol 17, 379-394. 
Shanbhag, N.M., and Greenberg, R.A. (2013). The dynamics of DNA damage repair 
and transcription. Methods Mol Biol 1042, 227-235. 
Sims, J.J., and Cohen, R.E. (2009). Linkage-specific avidity defines the lysine 63-
linked polyubiquitin-binding preference of rap80. Mol Cell 33, 775-783. 
Stewart, G.S., Panier, S., Townsend, K., Al-Hakim, A.K., Kolas, N.K., Miller, E.S., 
Nakada, S., Ylanko, J., Olivarius, S., Mendez, M., et al. (2009). The RIDDLE 
syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA 
damage. Cell 136, 420-434. 
Symington, L.S. (2014). End resection at double-strand breaks: mechanism and 
regulation. Cold Spring Harbor perspectives in biology 6, a016436. 
Tang, J., Cho, N.W., Cui, G., Manion, E.M., Shanbhag, N.M., Botuyan, M.V., Mer, 
G., and Greenberg, R.A. (2013). Acetylation limits 53BP1 association with damaged 
chromatin to promote homologous recombination. Nat Struct Mol Biol 20, 317-325. 
Tatsumi, K., Sou, Y.S., Tada, N., Nakamura, E., Iemura, S., Natsume, T., Kang, S.H., 
Chung, C.H., Kasahara, M., Kominami, E., et al. (2010). A novel type of E3 ligase for 
the Ufm1 conjugation system. J Biol Chem 285, 5417-5427. 
 17 
Tatsumi, K., Yamamoto-Mukai, H., Shimizu, R., Waguri, S., Sou, Y.S., Sakamoto, 
A., Taya, C., Shitara, H., Hara, T., Chung, C.H., et al. (2011). The Ufm1-activating 
enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat Commun 2, 
181. 
Tkac, J., Xu, G., Adhikary, H., Young, J.T., Gallo, D., Escribano-Diaz, C., Krietsch, 
J., Orthwein, A., Munro, M., Sol, W., et al. (2016). HELB Is a Feedback Inhibitor of 
DNA End Resection. Mol Cell 61, 405-418. 
Toledo, L.I., Altmeyer, M., Rask, M.B., Lukas, C., Larsen, D.H., Povlsen, L.K., 
Bekker-Jensen, S., Mailand, N., Bartek, J., and Lukas, J. (2013). ATR prohibits 
replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088-1103. 
van der Veen, A.G., and Ploegh, H.L. (2012). Ubiquitin-like proteins. Annu Rev 
Biochem 81, 323-357. 
Wagner, S.A., Beli, P., Weinert, B.T., Nielsen, M.L., Cox, J., Mann, M., and 
Choudhary, C. (2011). A proteome-wide, quantitative survey of in vivo ubiquitylation 
sites reveals widespread regulatory roles. Mol Cell Proteomics 10, M111 013284. 
Wu, X., and Karin, M. (2015). Emerging roles of Lys63-linked polyubiquitylation in 
immune responses. Immunol Rev 266, 161-174. 
Zeman, M.K., and Cimprich, K.A. (2014). Causes and consequences of replication 
stress. Nat Cell Biol 16, 2-9. 
 
 
Figure legends 
 
Figure 1. 
ZUFSP is a deubiquitylating enzyme 
A. Domain organization of human (Hs) ZUFSP and Schizosaccharomyces pombe (Sp) 
Mug105, showing location of predicted N-terminal ZnF, UBZ and MIU motifs and a 
C-terminal C78 Papain-like peptidase domain. B. Alignment of predicted ZUFSP 
catalytic cysteine and histidine residues based on the structure of UFSP2 (Ha et al., 
2011). Asterisk (*) marks the catalytic cysteine (C360) in ZUFSP. C. Extracts of 
U2OS cell lines stably expressing GFP-ZUFSP WT or C360A mutant were incubated 
with HA-tagged Ub-VS and subjected to HA immunoprecipitation (IP) followed by 
immunoblotting with indicated antibodies. Asterisk (*) indicates non-specific binding 
of GFP-ZUFSP to HA agarose. D. As in (C), but using extracts of U2OS cells or a 
derivative ZUFSP knockout (ZUFSPΔ) line. E. Average distance tree based on 
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alignment of the C78 peptidase domains and PAM250 scoring of the indicated 
proteins, showing that ZUFSP is more closely related to Mug105 than UFSP1/2. F. 
As in (C), using U2OS cells transfected with plasmids encoding GFP-Mug105 WT or 
C42A mutant. Asterisk (*) indicates non-specific binding of GFP-Mug105 to HA 
agarose. G. In vitro activity of recombinant ZUFSP WT and C360A towards Ub-
Rhodamine. 
See also Fig. S1. 
 
Figure 2. 
ZUFSP interacts with long K63-linked Ub chains via tandem UBZ and MIU 
motifs 
A. Schematic of ZUFSP fragments used in (B) and (E). B. GFP-ZUFSP proteins 
expressed in HEK293 cells were immunopurified on GFP-Trap agarose, incubated 
with recombinant K63-Ub3-7 chains and washed extensively. Bound complexes were 
immunoblotted with Ub antibody. C. Alignment of MIU motifs in ZUFSP and other 
human proteins (left), and of the ZUFSP UBZ domain with UBZ3 domains in human 
and Drosophila melanogaster (Dm) Polymerase η (Polη). D. As in (B), using GFP-
ZUFSP WT and recombinant mono-Ub or indicated K63-Ub chains. E. Binding of 
GFP-ZUFSP alleles containing inactivating point mutations in the UBZ and MIU 
motifs to Ub-K631-7 chains was analyzed as in (B). F. Analysis of GFP-ZUFSP WT 
binding to indicated tetra-K63 chains was performed as in (B). 
See also Fig. S1. 
 
Figure 3. 
ZUFSP selectively deubiquitylates K63 poly-Ub chains 
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A. Purified recombinant ZUFSP WT was incubated with indicated tetra-Ub linkages 
for 0 or 4 h. Reactions were resolved by SDS-PAGE and visualized by silver staining. 
B. Quantification of ZUFSP activity towards different tetra-Ub linkages (A). Ratios 
between tetra-Ub levels at 4 h and 0 h were determined by ImageJ Gel Analysis 
(meanSEM; n=3 independent experiments). C. As in (A), but using K48- or K63-
linked penta-Ub chains. D. Time-course analysis of ZUFSP WT and C360A activity 
towards K63-Ub8 chains, performed as in (A). E. Michaelis-Menten analysis of 
ZUFSP full-length (FL) and catalytic domain only (CD) (50 nM enzyme). Initial rates 
were taken at 15 s. F. Activity of full-length ZUFSP or CD towards K63-Ub8 chains 
was analyzed as in (A). 
See also Fig. S1, S2. 
 
Figure 4. 
ZUFSP promotes responses to replication stress 
A. U2OS/ER-mCherry-LacR-FokI-DD/LacO cells (Tang et al., 2013) transfected with 
empty vector expressing GFP only or GFP-ZUFSP constructs were treated with 4-
hydroxytamoxifen and Shield-1 for 5 h to induce clustered DSBs in a single LacO 
genomic locus (white arrow), then fixed and immunostained with γ-H2AX antibody. 
Representative images are shown. Scale bar, 10 μm. B. Quantification of results from 
(A), showing proportion of GFP-positive cells with GFP accumulation at 
FokI/γH2AX foci (meanSEM; at least 100 cells quantified per condition per 
experiment; n=3-7 independent experiments; ****p<0.0001, ***p<0.0005, unpaired 
t-test with Welch’s correction). C. U2OS/ER-mCherry-LacR-FokI-DD/LacO cells 
were transfected with indicated siRNAs, then transfected with GFP-ZUFSP WT 
plasmid and processed for DSB induction and immunostaining as in (A). Proportion 
 20 
of GFP-positive cells with GFP accumulation at FokI/γH2AX foci was determined 
(meanSEM normalized to siCTRL; 15-45 cells quantified per condition per 
experiment; n=3 independent experiments; **p<0.005, unpaired t-test with Welch’s 
correction). See also Fig. S3C. D. hTERT-RPE-1 cells transfected with indicated 
siRNAs were treated for 24 h with 0.2 μM aphidicolin (APH), 10 nM camptothecin 
(CPT) or 0.2 mM hydroxyurea (HU) prior to fixation and DAPI staining. Proportion 
of cells with micronuclei was determined (meanSEM; 400-800 cells quantified per 
condition per experiment; n=5 independent experiments; *p<0.05, **p<0.005, n.s. not 
significant, unpaired t-test with Welch’s correction). E. U2OS and derivative cells 
stably expressing GFP-ZUFSP WT were transfected with 3’ UTR-targeting ZUFSP 
siRNA (siZUFSP#20), treated with CPT for 1 h, washed and released into fresh 
medium for 24 h prior to fixation and immunostaining with RPA2 antibody in the 
presence of DAPI. Proportion of RPA2-positive micronuclei (example marked by 
arrow) was scored (meanSEM; 50-70 micronuclei analyzed per condition per 
experiment; n=2-4 independent experiments). F. Representative images of U2OS/2-6-
3 cells carrying a single LacO array (white arrow) that were synchronized at the G1/S 
border by a double thymidine block, transfected with constructs encoding GFP-
ZUFSP or GFP empty vector (EV), then released into S phase for 2 or 6 h in the 
presence of LacR-mCherry expression and fixed and immunostained with PCNA 
antibody. In the lower panel, cells were additionally pre-extracted and co-
immunostained with K63-Ub antibody. Scale bar, 10 μm. See Fig. S4F for additional 
time points. G. As in (F, lower panel), except that cells were transfected with 
indicated siRNAs. K63-Ub signal at individual LacR/LacO arrays (corrected for 
nuclear background signal) was quantified in cells released 6 h into S phase (bars, 
mean; >100 arrays analyzed per condition per experiment; ****p<0.0001, Mann-
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Whitney test). Data from a representative experiment are shown. H. U2OS and 
U2OS/GFP-ZUFSP cell lines transfected with control (CTRL) or 3’ UTR-targeting 
ZUFSP siRNA (siZUFSP#20) were treated with HU (2 mM) for 12 h, and where 
indicated washed and released into fresh medium for an additional 12 h. Cells were 
then immunostained with PCNA antibody in the presence of DAPI. Cell cycle profiles 
were determined by quantification of total DAPI content per nucleus. PCNA 
chromatin loading was used to determine the proportion of S phase cells (indicated). 
Data from a representative experiment are shown. I. As in (D), but using U2OS cells 
or derivative lines stably expressing GFP-ZUFSP transgenes (Fig. S4H) transfected 
with control (−) or a ZUFSP siRNA targeting the 3’-UTR (+) and treated with 0.2 μM 
aphidicolin for 24 h (meanSEM; 300-800 cells quantified per condition per 
experiment; n=3 independent experiments; *p<0.05, **p<0.005, n.s. not significant, 
unpaired t-test with Welch’s correction). 
See also Fig. S3,S4. 
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Provided as a separate file uploaded along with this submission. 
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Further information and requests for resources and reagents should be directed to and 
will be fulfilled by the Lead Contact, Niels Mailand (niels.mailand@cpr.ku.dk). 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Source of cell lines used in the study is reported in the Key Resources Table. 
 
METHOD DETAILS 
Plasmids and siRNAs 
Full-length human ZUFSP and UFSP2 cDNAs (in pENTR221 entry vector) were 
obtained from the Invitrogen Ultimate™ ORF Collection. Human codon-optimized 
mug105 cDNA was produced as a synthetic gene (IDT Gene Synthesis). Point 
mutations and deletions in ZUFSP (C360A; MIU*: A237G; UBZ*: C195G,C198G; 
ΔZnF1-3: deletion of amino acids (aa) 2-177; ΔCD: deletion of aa335-578; and Δ1-
310: deletion of aa1-310; Linker(+3): insertion of AAA after Q222; Linker(Δ3): 
deletion of aa 223-225) and Mug105 PD* (C42A) were introduced with the Q5 Site-
directed Mutagenesis Kit (NEB), according to the manufacturer’s protocol. Using 
Gateway LR Clonase (Invitrogen), cDNAs were inserted into the destination vector 
pcDNA4/TO/EGFP for doxycycline-inducible expression. For bacterial expression, 
cDNA encoding full-length human ZUFSP or the catalytic domain (CD) only (aa315-
578) was inserted into pGEX-6P-1 (Sigma Aldrich), or pET-NKI-his3C-LIC vector 
using ligation-independent cloning (Luna-Vargas et al., 2011). Plasmids for 
generation of U2OS ΔZUFSP cells using CRISPR/Cas9 were generated as described 
(Cong et al., 2013) using the pX459 plasmid (Addgene #62988) for Cas9 and gRNA 
delivery. Briefly, gRNA sequences were ordered as complementary primers, mixed in 
a 1:1 ratio and annealed. Subsequently, pX459 was digested with BbsI and the gRNA 
introduced using a normal ligation reaction according to the manufacturer’s 
instructions (New England Biolabs). The following sequences were used: ZUFSP 
sgRNA #3 (forward): 5’-CACCGGCGACAAAGGTTGGGGTTG-3’; ZUFSP sgRNA 
#3 (reverse): 5’-AAACCAACCCCAACCTTTGTCGCC-3’; ZUFSP sgRNA #14 
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(forward): 5’-CACCGAGCTCACCTAATTGTTCACA-3’; ZUFSP sgRNA #14 
(reverse): 5’-AAACTGTGAACAATTAGGTGAGCTC-3’. U2OS/ZUFSPΔ clones #1 
and #2 were derived from ZUFSP sgRNA #3, and U2OS/ZUFSPΔ #3 from ZUFSP 
sgRNA #14. 
Plasmid DNA and siRNA transfections were performed using FuGENE 6 
Transfection Reagent (Promega) and Lipofectamine RNAiMAX (Invitrogen), 
respectively, according to the manufacturers’ protocols. All siRNAs were used at a 
final concentration of 50 nM unless otherwise indicated. The following siRNA 
oligonucleotides were used: Non-targeting control (CTRL): 5’-
GGGAUACCUAGACGUUCUA-3’;  
ZUFSP(#9): 5’-GCAGAGACAAUAUGGUUUA -3’; ZUFSP(#20) (targeting the 
3’UTR): 5’-CUAAAAUGCCUGUGUUAAU-3’; RAD51: 5’-
GUAGAGAAGUGGAGCGUAA-3’; Ubc13: 5’-GAGCAUGGACUAGGCUAUA-3'; 
RPA1: 5’-GGAAUUAUGUCGUAAGUCA-3'; CtIP: 5’-
GCUAAAACAGGAACGAAUC-3’. 
Cell culture 
Human U2OS, HEK293 and hTERT-RPE-1 cells were obtained from ATCC. All cell 
lines used in this study were cultured in DMEM containing 10% FBS, and were 
regularly tested for mycoplasma infection. The cell lines were not authenticated. To 
generate U2OS cell lines inducibly expressing GFP-ZUFSP WT and mutant alleles, 
U2OS cells were co-transfected with pcDNA4/TO/GFP-ZUFSP constructs and 
pcDNA6/TR (Invitrogen) and positive clones were selected by incubation in medium 
containing blasticidin S (Invitrogen) and zeocin (Invitrogen) for 14 days. To generate 
U2OS ZUFSPΔ cell lines, parental cells were transfected with pX459-sgZUFSP #3 or 
#14 (gRNAs targeting unique sequences within the ZUFSP locus) and selected briefly 
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with puromycin during clonal selection. Clones were screened for ZUFSP expression 
by immunoblotting.  
Unless otherwise indicated, the following drug concentrations were used: 
camptothecin (10 nM, Sigma Aldrich), hydroxyurea (0.2 mM, Sigma Aldrich), 
aphidicolin (0.2 μM, Sigma Aldrich), and doxycycline (1 μg/ml, Sigma Aldrich).  
Immunoblotting, cell fractionation and antibodies 
For immunoblotting and immunoprecipitation, which were done as described 
(Poulsen et al., 2012), cells were lysed in EBC buffer (50 mM Tris, pH 7.5; 150 mM 
NaCl; 1 mM EDTA; 0.5% NP40; 1 mM DTT) supplemented with protease and 
phosphatase inhibitors. Lysates were then incubated 10 min on ice and sonicated. For 
immunoprecipitations, lysates were additionally treated with benzonase to minimize 
chromatin-mediated interactions. 
Antibodies used in this study included: 53BP1 (sc-22760, Santa Cruz (1:500)), Actin 
(MAB1501, Millipore (1:20,000 dilution), CHK1 pSer345 (2348, Cell Signaling 
(1:1,000)), CHK2 pThr68 (2661, Cell Signaling (1:500)), CtIP (A300-488A, Bethyl 
(1:1,000)), GFP (sc-9996 (Clone B2), Santa Cruz (1:1,000)), γ-H2AX (05-636 (Clone 
JBW301), Millipore (1:500)), HA (11867423001 (Clone 3F10), Roche (1:1,000)), 
p97 (ab11433, Abcam (1:5,000)), RAD51 (PC130, Ab-1, Millipore (1:500)), RPA1 
(Ab79398, Abcam (1:1,000)), RPA2 (NA19L (Clone Ab-3), Calbiochem (1:1,000)), 
RPA2 pSer4/Ser8 (A300-245A, Bethyl (1:1,000)), PCNA (#2037, Triolab 
Immunoconcepts (1:500)), Polyubiquitin K63 linkage-specific (BML-PW0600, Enzo 
life sciences (1:200)), SENP6 (NPB1-82958, Novus Bio (1:5,000)), Ubc13 (37-1100 
(Clone 4E11), Invitrogen (1:3,000)), Ubiquitin (sc-8017 (Clone P4D1), Santa Cruz 
(1:1,000)), USP7 (A300-033A, Bethyl (1:5,000)). Polyclonal sheep antibody to 
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ZUFSP was raised against full-length recombinant human ZUFSP, purified from 
bacteria. 
Purification of recombinant ZUFSP proteins 
GST-ZUFSP, GST-ZUFSP C360A and His6-ZUFSP CD were expressed in E. coli 
RosettaTM2(DE3) induced with 0.2 mM IPTG and grown at 20 °C overnight. For 
GST-ZUFSP and GST-ZUFSP C360A, cells were pelleted and resuspended in 50 mM 
HEPES pH 7.5; 150 mM NaCl; 1 mM DTT and Pierce protease inhibitor. Cells were 
lysed on ice by sonication (Qsonica) in the presence of 5 µg/ml DNase I (Sigma). The 
cell lysate was centrifuged at 30,000g for 40 min at 4 °C. The supernatant was first 
clarified by a 0.45-μm-syringe filter and loaded onto a gravity column containing 3 ml 
Glutathione Sepharose 4B (GE Healthcare) and incubated at 4 °C for 30 min. The 
resin was washed with 20 mM HEPES pH 7.5; 600 mM NaCl; 1 mM DTT, and then 
eluted with 20 mM HEPES, pH 7.5; 150 mM NaCl; 1mM DTT; 20mM glutathione. 
The GST-tag was removed by 3C protease at 4 °C for 4 h. Finally, the tag-free protein 
was loaded onto the Hiload 16/60 Superdex 200 column equilibrated in 20 mM 
HEPES pH 7.5; 150 mM NaCl; 1 mM DTT. The elution fractions containing ZUFSP 
or ZUFSP C360A were concentrated to desired concentration. His6-ZUFSP CD was 
purified in a similar way as GST-ZUFSP, but lysed in 50 mM Tris-HCl, pH 8.0; 200 
mM NaCl; 20 mM imidazole; 1 mM DTT and Pierce protease inhibitor. The 
supernatant from centrifugation was loaded onto 2 ml Ni-Sepharose columns and 
washed with 50 mM Tris-HCl, pH 8.0; 200 mM NaCl; 20 mM imidazole; 1 mM 
DTT. The protein was eluted by 50 mM Tris-HCl, pH 8.0; 200 mM NaCl; 500 mM 
imidazole; 1mM DTT, and further purified by a Hiload 16/60 Superdex 75 column 
equilibrated with 20 mM HEPES; 200 mM NaCl; 1 mM DTT.  
DUB assays 
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To assay for reactivity of peptidases with Ub- and SUMO vinyl sulfone (VS) probes, 
U2OS cells were lysed under mild conditions (50 mM Tris, pH 8.0; 50mM NaCl; 
5mM DTT; 0.2% Triton X-100; 50 µM PMSF), briefly sonicated and cleared by 
centrifugation. The lysate was then incubated with 0.5 µM recombinant HA-tagged 
Ub-VS or SUMO1-VS (#U-212-025 and # UL-703-050, Boston Biochem) for 1 h at 
37°C with gentle shaking, diluted in denaturing buffer (20 mM Tris, pH 7.5; 50 mM 
NaCl; 1 mM EDTA; 1 mM DTT; 0.5% NP-40; 0.5% sodium deoxycholate; 0.5% 
SDS) and subjected to immunoprecipitation with anti-HA agarose (A2095, Sigma 
Aldrich) followed by immunoblotting. 
For analysis of ZUFSP activity towards purified Ub chains (purchased from Boston 
Biochem and pre-diluted to 0.3 µg/µL in 2xDUB buffer (100 mM NaCl, 100 mM 
Tris-HCl, pH 7.5; 10 mM DTT)), recombinant ZUFSP was diluted to 2 µM in DUB 
dilution buffer (150 mM NaCl; 25mM Tris-HCl, pH 7.5; 10 mM DTT), incubated at 
room temperature for 15 min, mixed 1:1 with Ub chains and incubated at 30 °C with 
gentle shaking. Reactions were terminated by addition of Laemmli sample buffer and 
boiled for 5 min. Samples were resolved by SDS-PAGE and analyzed by silver 
staining (Pierce Silver Stain Kit, Thermo Scientific) according to the manufacturer’s 
instructions. 
Enzyme activity against Ub N-terminal Rhodamine (Boston Biochem) was measured 
by a Pherastar fluorescence plate reader (BMG) with 384-well non-binding surface, 
flat bottom, low flange, black plates (Corning). The fluorescence intensity from free 
Rhodamine was detected using 480 nm as excitation and 520 nm as emission 
wavelengths. All enzymes and substrate were prepared in 20 mM HEPES, pH7.5; 150 
mM NaCl; 1 mM DTT; 0.02% Tween-20; 1 mg/ml BSA, and all experiments were 
done at 25 °C. For single-point assays 100 nM ZUFSP WT or C360A were injected 
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into wells containing 15 µl Ub-Rhodamine (1 µM) in a total volume of 30 µl. For 
kinetic analysis of ZUFSP FL and CD, a plate was prepared with serially diluted 30 
µM Ub-Rhodamine (15 µl fractions), and the reaction was started by injection of 15 
µl enzyme within the Pherastar. Fluorescence signals were recorded from 1.5 s after 
injection, at 1-s intervals until 50.5 s. Each enzyme was analyzed at 3 different 
concentrations (200 nM, 100 nM and 50 nM) and all measurements were repeated 
twice. For analysis, we performed detailed kinetic analysis and kinetic modeling using 
the software KinTek Explorer 6.3 (Johnson et al., 2009a, b). In this analysis we used a 
simple Michaelis-Menten model with correction for the signal decrease due to the 
adsorption of free Rhodamine to well surfaces. The association constant was 
fixed (kon=10 μM-1s-1) to reflect a diffusion-limited process. 
Ub-binding assays 
HEK293 or U2OS cells expressing GFP-ZUFSP alleles were lysed in denaturing 
buffer supplemented with protease inhibitors, and extracts were sonicated and cleared 
by centrifugation. GFP-tagged ZUFSP was then purified on GFP-Trap agarose 
(Chromotek) followed by extensive washing in denaturing buffer. The beads were 
equilibrated in EBC buffer and incubated with recombinant Ub chains (0.5-1 
µg/sample, Boston Biochem) for 2 h at 4°C with rotation. Bound material was washed 
5 times in EBC buffer, eluted by boiling in 2x Laemmli sample buffer for 5 min and 
analyzed by immunoblotting. Pull-down experiments with Ub, SUMO1, SUMO2 and 
UFM1 coupled to agarose beads via primary amines (Boston Biochem) were 
performed using similar binding buffer (EBC) and washing conditions.  
Immunofluorescence and high-content imaging analysis 
Cells were pre-extracted in PBS containing 0.2% Triton X-100 for 2 min on ice, 
before fixation with 4% formaldehyde for 10 min. If cells were not pre-extracted, they 
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were subjected a permeabilization step with PBS containing 0.2% Triton X-100 for 5 
min and incubated with primary antibodies diluted in 1% BSA-PBS for 1 h at room 
temperature. Following staining with secondary antibodies (Alexa Fluor; Life 
Technologies) diluted in 1% BSA-PBS for 1 h at room temperature, coverslips were 
mounted in Vectashield mounting medium (Vector Laboratories) containing nuclear 
stain DAPI. Laser microirradiation was performed as described (Mosbech et al., 
2012). Induction and analysis of FokI-induced DSBs was done as described 
previously (Tang et al., 2013). Briefly, U2OS 2-6-5 cells expressing inducible ER-
mCherry-LacR-FokI-DD (a kind gift from Roger Greenberg, University of 
Pennsylvania) were treated with 4-hydroxytamoxifen (300 nM, Sigma Aldrich) and 
Shield-I (1 µM, Clontech) for 5 h to allow for the expression of and induction of 
DSBs by the FokI nuclease. Cells were then fixed, permeabilized and immunostained 
as described. Analysis of LacR-induced replication blockage in U2OS 2-6-3 cells 
carrying a single LacO array on Chromosome 1 (a kind gift from Susan Janicki, 
University of Pennsylvania) (Janicki et al., 2004) was performed by synchronizing 
cells at the G1/S border by a double thymidine block. Cells were then washed 
extensively and released into S phase while expressing LacR-mCherry. Subsequently, 
cells were fixed, permeabilized and immunostained at regular intervals (2, 4, 6, 10 h) 
to establish the replication timing of the array (PCNA) and recruitment kinetics of 
GFP-ZUFSP and endogenous K63-linked poly-Ub (cells were pre-extracted to detect 
K63-linked poly-Ub). 
Images were acquired with a Leica AF6000 wide-field microscope (Leica 
Microsystems) equipped with HC Plan-Apochromat 63x/1.4 oil immersion objective, 
using standard settings. Image acquisition and analysis was carried out with LAS X 
software (Leica Microsystems). Raw images were exported as TIFF files and if 
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adjustments in image contrast and brightness were applied, identical settings were 
used on all images of a given experiment. For cell cycle analysis by EdU staining, 
cells were treated with EdU (10 μM) for 30 min before fixation, then stained using the 
Click-iT® Plus EdU Alexa Fluor 647 Imaging Kit (Invitrogen) according to the 
manufacturer’s instructions. Quantitative image-based cytometry (QIBC) was 
performed as described (Toledo et al., 2013). Briefly, cells were fixed, permeabilised 
and stained as described above. Nuclear DNA was counterstained with DAPI 
(Molecular Probes) alongside incubation with secondary antibodies. Cells were 
mounted onto glass slides using ProLong® Gold Antifade (Invitrogen, Molecular 
Probes). Images were acquired with an Olympus IX-81 wide-field microscope 
equipped with an MT20 Illumination system and a digital monochrome Hamamatsu 
C9100 CCD camera. Olympus UPLSAPO 10x/0.4 NA, 20x/0.75 NA objectives were 
used. Automated and unbiased image analysis was carried out with the ScanR 
analysis software. Data was exported and processed using Spotfire (Tibco) software. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Statistical analysis of data was performed using GraphPad Prism (version 7). 
Information about statistical tests is provided in the figure legends. No samples were 
excluded from the analysis and no statistical method was used to predetermine sample 
size. For all experiments, samples were not randomized and the investigators were not 
blinded to the group allocation during experiments and outcome assessment. 
 
DATA AND SOFTWARE AVAILABILITY  
Original imaging data have been deposited to Mendeley Data and are available at 
http://dx.doi.org/10.17632/89twmd4sd7.1. 
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KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
anti-53BP1 Santa Cruz 
Biotechnology 
Cat# sc-22760 
Anti-Actin Millipore Cat# MAB1501 
Anti-CHK1 pSer345 Cell Signaling Cat# 2348 
Anti-CHK2 pThr68 Cell Signaling Cat# 2661 
Anti-CtIP Bethyl Cat# A300-488A 
Anti-GFP Santa Cruz 
Biotechnology 
Cat# sc-9996 
Anti-γ-H2AX Millipore Cat# 05-636 
Anti-HA-tag Roche Cat# 
11867423001 
Anti-p97 Abcam Cat# Ab11433 
Anti-RAD51 Millipore Cat# PC130 
anti-RPA1 Abcam Cat# Ab79398 
Anti-RPA2 Calbiochem Cat# NA19L 
Anti-RPA2 pSer4/Ser8 Bethyl Cat# A300-245A 
Anti-PCNA Triolab Immunoconcepts Cat# 2037 
Anti-SENP6 Novus Bio Cat# NPB1-82958 
Anti-Ubc13 Invitrogen Cat# 37-1100 
Anti-Ubiquitin Santa Cruz 
Biotechnology 
Cat# sc-8017 
Anti-USP7 Bethyl Cat# A300-033A 
Anti-K63-Ub Enzo life sciences Cat# BML-
PW0600 
Sheep polyclonal Anti-ZUFSP Custom made N/A 
Anti-mouse 488 Molecular probes Cat# A-11001 
Anti-human 647 TriChem Cat# 709-606-149 
Anti-rabbit 488 Molecular probes Cat# A-11008 
Anti-mouse 568 Molecular probes Cat# A-10037 
Anti-rabbit 568 Molecular probes Cat# A-11011 
Anti-mouse HRP Vector laboratories Cat# PI-2000 
Anti-rabbit HRP Vector laboratories Cat# PI-1000 
Anti-sheep HRP DAKO Cat# P0163 
   
Bacterial and Virus Strains  
E. coli RosettaTM2(DE3) N/A N/A 
   
   
   
   
Key Resource Table
 Chemicals, Peptides, and Recombinant Proteins 
Camptothecin Sigma Aldrich Cat# C9911 
Hydroxyurea Sigma Aldrich Cat# H8627 
Aphidicolin Sigma Aldrich Cat# A0781 
Doxycycline Sigma Aldrich Cat# D9891 
4-hydroxytamoxifen Sigma Aldrich Cat# H7904 
Shield-I Clontech Cat# 632188 
Thymidine Sigma Aldrich Cat# T9250 
Protein inhibitor cocktail Sigma Aldrich Cat# P2714 
Phosphatase inhibitor cocktail Roche Cat# 
04906837001 
Benzonase Sigma Aldrich Cat# E1014 
Blasticidin S Invitrogen Cat# ant-bl-1 
Zeocin Gibco Cat# R25005 
FuGENE 6 Transfection Reagent Promega Cat# E2692 
Lipofectamine RNAiMAX Invitrogen Cat# 13778150 
DAPI Molecular Probes Cat# D1306 
ProLong Gold Antifade Molecular Probes Cat# P36930 
GFP-Trap agarose Chromotek Cat# gta-100 
IPTG AppliChem Cat# A4773 
Ubiquitin agarose Boston Biochem Cat# U-400 
UFM1 agarose Boston Biochem Cat# UL-530 
SUMO1 agarose Boston Biochem Cat# UL-740 
SUMO2 agarose Boston Biochem Cat# UL-755 
HA-Ubiquitin-VS Boston Biochem Cat# U-212-025  
HA-SUMO1-VS Boston Biochem Cat# UL-703-050 
Anti-HA agarose Sigma Aldrich Cat# A2095 
Ub-Rhodamine110 Boston Biochem Cat# U-555 
Ub2, M1-linked Boston Biochem Cat# UC-700B 
Ub2, K6-linked Boston Biochem Cat# UC-11B 
Ub2, K11-linked Boston Biochem Cat# UC-40B 
Ub2, K27-linked Boston Biochem Cat# UC-61 
Ub2, K29-linked Boston Biochem Cat# UC-81B 
Ub2, K33-linked Boston Biochem Cat# UC101B 
Ub2, K48-linked Boston Biochem Cat# UC-200B 
Ub2, K63-linked Boston Biochem Cat# UC-300B 
Ub4, M1-linked Boston Biochem Cat# UC-710B 
Ub4, K6-linked Boston Biochem Cat# UC-15 
Ub4, K11-linked Boston Biochem Cat# UC-45 
Ub4, K29-linked Boston Biochem Cat# UC-83 
Ub4, K33-linked Boston Biochem Cat# UC-103 
Ub4, K48-linked Boston Biochem Cat# UC-210B 
Ub4, K63-linked Boston Biochem Cat# UC-310B 
Ub5, K48-linked Boston Biochem Cat# UC-216 
Ub5, K63-linked Boston Biochem Cat# UC-316 
 Ub8, K63-linked Boston Biochem Cat# UC-318 
Ub1-7, K63-linked Boston Biochem Cat# UC-340 
Ub3-7, K63-linked Boston Biochem Cat# UC-320 
Recombinant ZUFSP (FL) This paper N/A 
Recombinant ZUFSP (CD) This paper N/A 
Recombinant ZUFSP C360A This paper N/A 
Critical Commercial Assays 
Pierce Silver Stain Kit Thermo Scientific Cat# 24612 
Click-iT Plus EdU Alexa Fluor 647 Imaging Kit Invitrogen Cat# C10640 
Q5 Site-directed Mutagenesis Kit NEB Cat# E0554S 
   
Deposited Data 
Raw imaging data This paper http://dx.doi.org/10
.17632/89twmd4sd
7.1 
   
Experimental Models: Cell Lines 
U2OS ATCC HTB-96 
HEK293T ATCC CRL-11268 
hTERT-RPE-1 ATCC CRL-4000 
U2OS GFP-ZUFSP WT This paper N/A 
U2OS GFP-ZUFSP C360A This paper N/A 
U2OS GFP-ZUFSP MIU* (A237G) This paper N/A 
U2OS GFP-ZUFSP UBZ* (C195G/C198G) This paper N/A 
U2OS GFP-ZUFSP MIU* + UBZ* This paper N/A 
U2OS GFP-ZUFSP ΔZnF1-3 (ΔAA2-177) This paper N/A 
U2OS ZUFSPΔ This paper N/A 
U2OS 2-6-3 Susan Janicki lab Janicki et al., 2004 
U2OS 2-6-5 ER-mCherry-lacR-FokI-DD Roger Greenberg lab Tang et al., 2013 
   
Experimental Models: Organisms/Strains 
   
   
Oligonucleotides 
siCTRL: 5’-GGGAUACCUAGACGUUCUA-3’ Thorslund et al., 2015 N/A 
siZUFSP(#9): 5’-GCAGAGACAAUAUGGUUUA -3’ This paper N/A 
siZUFSP(#20): 5’-CUAAAAUGCCUGUGUUAAU-3’ This paper N/A 
siRAD51: 5’-GUAGAGAAGUGGAGCGUAA-3’ Haahr et al., 2016 N/A 
siUbc13: 5’-GAGCAUGGACUAGGCUAUA-3' Thorslund et al., 2015 N/A 
siRPA1: 5’-GGAAUUAUGUCGUAAGUCA-3' Haahr et al., 2016 N/A 
siCtIP: 5’-GCUAAAACAGGAACGAAUC-3’ Haahr et al., 2016 N/A 
ZUFSP sgRNA#3 (forward): 5’-
CACCGGCGACAAAGGTTGGGGTTG-3’ 
This paper N/A 
ZUFSP sgRNA#3 (reverse): 5’-
AAACCAACCCCAACCTTTGTCGCC-3’ 
This paper N/A 
ZUFSP sgRNA#14 (forward): 5’-
CACCGAGCTCACCTAATTGTTCACA-3’ 
This paper N/A 
 ZUFSP sgRNA#14 (reverse): 5’-
AAACTGTGAACAATTAGGTGAGCTC-3’ 
This paper N/A 
   
Recombinant DNA 
pcDNA4/TO/EGFP Invitrogen  
pcDNA4/TO/EGFP ZUFSP WT This paper N/A 
pcDNA4/TO/EGFP ZUFSP C360A This paper N/A 
pcDNA4/TO/EGFP ZUFSP MIU* This paper N/A 
pcDNA4/TO/EGFP ZUFSP UBZ* This paper N/A 
pcDNA4/TO/EGFP ZUFSP MIU* + UBZ* This paper N/A 
pcDNA4/TO/EGFP ZUFSP ΔZnF1-3 This paper N/A 
pcDNA4/TO/EGFP ZUFSP Δ1-310 This paper N/A 
pcDNA4/TO/EGFP ZUFSP ΔCD This paper N/A 
pcDNA4/TO/EGFP ZUFSP Linker+3 This paper N/A 
pcDNA4/TO/EGFP ZUFSP LinkerΔ3 This paper N/A 
pcDNA4/TO/EGFP UFSP2 This paper N/A 
pcDNA4/TO/EGFP Mug105 This paper N/A 
pcDNA4/TO/EGFP Mug105 C42A This paper N/A 
pGEX-6P-1 Sigma Aldrich  
pGEX-6P-1 ZUFSP FL This paper N/A 
pGEX-6P-1 ZUFSP CD (AA315-578) This paper N/A 
pET-NKI-his3C-LIC Titia Sixma lab N/A 
pET-NKI-his3C-LIC ZUFSP FL This paper N/A 
pET-NKI-his3C-LIC ZUFSP CD This paper N/A 
pX459 Feng Zhang lab Addgene plasmid 
#48139 
pX459-ZUFSP sgRNA#3 This paper N/A 
pX459-ZUFSP sgRNA#14 This paper N/A 
   
Software and Algorithms 
GraphPad Prism 7 for Mac OS X GraphPad Software https://www.graph
pad.com/scientific-
software/prism/ 
ImageJ ImageJ Software https://imagej.net/
Downloads 
ScanR analysis software Olympus https://www.olymp
us-
lifescience.com/ 
Spotfire software Tibco https://spotfire.tibc
o.com/ 
LAS X Software Leica Microsystems https://www.leica-
microsystems.com 
KinTek Explorer, Version 6.3 KinTek Corporation https://kintekcorp.c
om/software/ 
   
Other 
   
   
   




Supplemental Text and Figures
Figure S1. Related to Figure 1-3 
Ub-binding and DUB activity of ZUFSP 
A. Extracts of U2OS cells stably expressing indicated GFP-ZUFSP alleles were 
incubated with immobilized Ub, UFM1-, SUMO1- or SUMO2-agarose, washed 
extensively and immunoblotted with GFP antibody. B. Extracts of U2OS cells stably 
expressing GFP-ZUFSP WT were incubated with HA-tagged Ub or SUMO1 vinyl 
sulfone (VS), subjected to HA immunoprecipitation followed by immunoblotting with 
indicated antibodies. SENP6 is a positive control for reactivity with SUMO1-VS. C. 
Extracts of U2OS cells transiently transfected with GFP-UFSP2 expression plasmid 
were treated as in (B). D. GFP-only (empty vector, EV) or GFP-ZUFSP proteins 
containing a three-amino acid insertion (Linker+3) or deletion (LinkerΔ3) were 
expressed in HEK293 cells and immunopurified on GFP-Trap agarose, incubated with 
recombinant K63-Ub1-7 chains and washed extensively. Bound complexes were 
immunoblotted with Ub antibody. E. Bacterially purified, recombinant ZUFSP WT 
was incubated with indicated di-Ub linkages for 0 or 6 h. Reactions were resolved by 
SDS-PAGE and visualized by silver staining. F. As in (E), except that recombinant 
ZUFSP WT was incubated with indicated tetra-Ub linkages for 18 h. 
 

Figure S2. Related to Figure 3 
Kinetic modeling of ZUFSP DUB activity 
A. Fitting of Ub-Rhodamine kinetic assays by KinTek Explorer to a simple 
Michaelis-Menten model, with correction for the signal decrease due to the adsorption 
of free Rhodamine (Rh to Rhi) to well surfaces. The association constant was fixed 
(kon = 10 µM-1s-1) to reflect a diffusion-limited process, and reverse reactions were 
assumed not to be relevant. Joint data fitting for FL and CD at two protein 
concentrations. Raw data shown as dots and fitted curves as solid line. Initial fitting 
was performed with individual kcat values (k2 and k5). As they refined to equal values, 
the value was fixed equivalent, and the overall fitting improved. B. chi2 plots for each 
individual parameter that allow definition of upper and lower boundaries for the 
parameter. C. Chi2min/Chi2x,y plots of pair-wise 2-dimensional search. These figures 
reveal that complex relationships exist between these parameters. 
 

Figure S3. Related to Figure 4 
ZUFSP is dispensable for responses to DSBs 
A. Representative images showing GFP-ZUFSP co-localization with RPA1 in 
microfoci in a subset of cells exposed to laser microirradiation-induced DSBs. U2OS 
cells transiently expressing GFP-ZUFSP were subjected to laser microirradiation. 
Fifty min later, cells were pre-extracted and co-immunostained with RPA1 and 
γH2AX antibodies. Scale bar, 10 µm. B. U2OS/ER-mCherry-LacR-FokI-DD/LacO 
cells transfected with GFP-ZUFSP WT plasmid were treated with 4-
hydroxytamoxifen and Shield-1 for 5 h to induce clustered DSBs within a single 
LacO genomic locus, then fixed and immunostained with RPA1 antibody. 
Representative images are shown. Scale bar, 10 µm. C. Immunoblot analysis of 
U2OS/ER-mCherry-LacR-FokI-DD/LacO cells transfected with indicated siRNAs. 
See also Fig. 4B,C. D. U2OS cells stably expressing indicated versions of GFP-
ZUFSP were treated with camptothecin (CPT, 1 µM) for 2 h and processed for GFP 
immunoprecipitation followed by immunoblotting with RPA and GFP antibodies. E. 
Representative images of U2OS cells transiently expressing GFP-ZUFSP WT treated 
with campthothecin (CPT, 1 µM) for 1 h. Cells were then fixed and immunostained 
with RPA1 antibody. Scale bar, 10 µm. F. Immunoblot analysis of U2OS cells (−) or 
derivative ZUFSP knockout (ZUFSPΔ) lines treated or not with campthothecin (CPT, 
1 µM) for 1 h. See Fig. S4D for immunoblot analysis of ZUFSP expression. G. U2OS 
cells transfected with GFP-ZUFSP WT expression plasmid were subjected to ionizing 
radiation (IR, 2 Gy) and fixed at the indicated time points. Cells were then co-
immunostained with 53BP1 and γ-H2AX antibodies. Representative images are 
shown. Scale bar, 10 µm. H. As in (G), except that U2OS cells were transfected with 
the indicated siRNAs prior to IR treatment. Proportion of cells containing >10 53BP1 
foci was determined (mean±SEM; 150-200 cells quantified per condition per 
experiment; n=2 independent experiments). 
 

Figure S4. Related to Figure 4 
ZUFSP functions in the replication stress response 
A. U2OS cells or derivative ZUFSP knockout (ZUFSPΔ) lines were treated or not 
with aphidicolin (0.2 µM) for 24 h, then fixed and stained with DAPI. Proportion of 
cells with micronuclei was determined (mean±SEM; 400 cells quantified per 
condition; n=2 independent experiments). See also Fig. S4D. B. U2OS cells 
transfected with indicated ZUFSP siRNAs were treated and processed as in (A) 
(mean±SEM; 400 cells quantified per condition; n=2-4 independent experiments). See 
also Fig. S4C. C. Immunoblot analysis of U2OS cells transfected with control siRNA 
(siCTRL) or siRNAs targeting ZUFSP for 48 h. D. Immunoblot analysis of parental 
U2OS cells and derivative ZUFSP knockout (ZUFSPΔ) lines. E. U2OS cells treated 
with indicated siRNAs were treated with HU (2 mM) for 4 h, fixed and 
immunostained with γ-H2AX antibody in the presence of DAPI, and analyzed by high 
content microscopy. Proportion of cells with low (green), medium (blue) and high 
(pink) γ-H2AX signal is indicated. At least 4000 cells were analyzed per condition. 
Data from a representative experiment are shown. F. Representative images of 
U2OS/2-6-3 cells carrying a single LacO array (white arrow) that were synchronized 
at the G1/S border by a double thymidine block, transfected with constructs encoding 
GFP-ZUFSP or GFP empty vector (EV), then released into S phase for the indicated 
times in the presence of LacR-mCherry expression and fixed and immunostained with 
PCNA antibody. In the lower panel, cells were additionally pre-extracted and co-
immunostained with K63-Ub antibody. Scale bar, 10 µm. G. Quantitative image 
analysis of asynchronously growing U2OS cells and U2OS cells depleted of ZUFSP 
that were labelled with EdU and stained with DAPI (n=2000 cells per condition). The 
proportion of cells in different cell cycle phases (pink: G1 phase; blue: S phase; 
green: G2/M phase) is indicated. H. Immunoblot analysis of U2OS cells or derivative 
cell lines stably expressing the indicated GFP-ZUFSP transgenes.  
 
